169867 - Medication Assisted Treatment for Opioid Dependence (MATOD) - Module 2 - for Victorian GPs
The aim of this workshop is to provide prescribers (GPs and nurse practitioners) with the skills and confidence to assess, manage and initiate patients on Opioid Replacement Therapy.
On successfully completing the 2 hour prerequisite online learning module (Part A) on the principles of Safer Opioid Prescribing and attendance at this 4 hour face to face workshop (Part B), prescribers will be authorised to prescribe Medication Assisted Treatment for Opioid Dependence to >5 patients.
Evidence indicates that Medication Assisted Treatment for Opioid Dependence decreases opioid drug use, reduces illness and death from drug use, reduces criminal activity, reduces high risk needle sharing and enhances social responsibility and productivity.
Because of the special characteristics of this field of treatment, practice in Victoria to prescribe buprenorphine for more than 5 patients or methadone is limited to prescribers who have been adequately trained and approved by the Drugs and Poisons Regulation Group of the Department of Health and Human Services.
It has been estimated that on any given day in 2015, there were 44,522 people being treated with pharmacotherapy in Australia. In July 2015, there were around 14,122 patients receiving pharmacotherapy in Victoria (two-thirds on methadone and one-third on buprenorphine).
Ref 'Policy for Maintenance pharmacotherapy for Opioid Dependence' Published by Department of Health and Human Services, revised 2016.